BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 36357543)

  • 1. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
    Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
    Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.
    Köstenberger M; Nahler G; Jones TM; Neuwersch S; Likar R
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):318-333. PubMed ID: 34467511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of cannabidiol trials in neurodevelopmental disorders.
    Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
    Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
    Vimal D; D'Souza LC; Rai V; Lal S; Sharma A; Gupta SC
    Curr Med Chem; 2023; 30(2):178-202. PubMed ID: 35619266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential.
    Coelho MP; Duarte P; Calado M; Almeida AJ; Reis CP; Gaspar MM
    Life Sci; 2023 Sep; 329():121838. PubMed ID: 37290668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
    Anand U; Pacchetti B; Anand P; Sodergren MH
    Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis-Based Products for Chronic Pain : A Systematic Review.
    McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R
    Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
    Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
    J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
    Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.